Zoetis (ZTS) — insider trading
Health Care · NYSE
Zoetis (ZTS) has 37 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases among the most recent 37 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | FULLER JULIE | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 799 | — | — | Form 4 |
| 2026-09-30 | FULLER JULIE | Officer (Executive Vice President) | Shares withheld for taxes / exercise cost | 274 | $69.83 | $19.1K | Form 4 |
| 2026-09-30 | FULLER JULIE | Officer (Executive Vice President) | Option exercise / conversion | 799 | — | — | Form 4 |
| 2026-09-17 | Stetter Mark | Director | Grant / award / vesting (derivative) | 342 | $73.02 | $25.0K | Form 4 |
| 2026-08-31 | SACCARO JAMES | Officer (EVP, CFO & COO) | Grant / award / vesting (derivative) | 81,063 | — | $0 | Form 4 |
| 2026-08-07 | DAMELIO FRANK A | Director | Bona fide gift | 6,650 | — | $0 | Form 4 |
| 2026-07-10 | Joseph Wetteny | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 363 | $26.22 | $9.5K | Form 4 |
| 2026-07-10 | Ferran Astorga Jeannette | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 45 | $26.22 | $1.2K | Form 4 |
| 2026-07-10 | Lagano Roxanne | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 315 | $26.22 | $8.3K | Form 4 |
| 2026-07-10 | FULLER JULIE | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 315 | $26.22 | $8.3K | Form 4 |
| 2026-07-10 | Driscoll Rimma | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 238 | $26.22 | $6.2K | Form 4 |
| 2026-07-10 | Esch Kevin | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 308 | $26.22 | $8.1K | Form 4 |
| 2026-07-10 | Nayak Abhay U | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 215 | $26.22 | $5.6K | Form 4 |
| 2026-07-10 | PECK KRISTIN C | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 616 | $26.22 | $16.2K | Form 4 |
| 2026-07-10 | Sarbaugh Keith | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 260 | $26.22 | $6.8K | Form 4 |
| 2026-06-18 | Stetter Mark | Director | Grant / award / vesting (derivative) | 318 | $78.71 | $25.0K | Form 4 |
| 2026-06-10 | MCCALLISTER MICHAEL B | Director | Bona fide gift | 1,209 | — | $0 | Form 4 |
| 2026-05-21 | Stetter Mark | Director | Option exercise / conversion (derivative) | 1,572 | — | — | Form 4 |
| 2026-05-21 | Stetter Mark | Director | Option exercise / conversion | 1,572 | — | — | Form 4 |
| 2026-05-20 | PARENT LOUISE M | Director | Option exercise / conversion (derivative) | 10,187 | — | $0 | Form 4 |
| 2026-05-20 | PARENT LOUISE M | Director | Option exercise / conversion (derivative) | 1,944 | — | $0 | Form 4 |
| 2026-05-20 | PARENT LOUISE M | Director | Option exercise / conversion | 10,186 | — | — | Form 4 |
| 2026-05-20 | PARENT LOUISE M | Director | Option exercise / conversion | 1,944 | — | — | Form 4 |
| 2026-05-13 | Bisaro Paul | Director | Open-market purchase | 2,000 | $75.88 | $151.8K | Form 4 |
| 2026-05-13 | DAMELIO FRANK A | Director | Open-market purchase | 6,650 | $75.39 | $501.3K | Form 4 |
| 2026-05-11 | MCCALLISTER MICHAEL B | Director | Open-market purchase | 3,000 | $77.76 | $233.3K | Form 4 |
| 2026-04-30 | Esch Kevin | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 260 | — | — | Form 4 |
| 2026-04-30 | Esch Kevin | Officer (Executive Vice President) | Shares withheld for taxes / exercise cost | 75 | $114.97 | $8.6K | Form 4 |
| 2026-04-30 | Esch Kevin | Officer (Executive Vice President) | Option exercise / conversion | 259 | — | — | Form 4 |
| 2026-04-10 | Sarbaugh Keith | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 231 | $39.64 | $9.1K | Form 4 |
| 2026-04-10 | Joseph Wetteny | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 874 | $39.64 | $34.6K | Form 4 |
| 2026-04-10 | Driscoll Rimma | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 26 | $39.64 | $1.0K | Form 4 |
| 2026-04-10 | PECK KRISTIN C | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 2,777 | $39.64 | $110.1K | Form 4 |
| 2026-04-10 | Esch Kevin | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 1 | $39.64 | $55 | Form 4 |
| 2026-04-10 | Ferran Astorga Jeannette | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 5 | $39.64 | $198 | Form 4 |
| 2026-04-10 | Lagano Roxanne | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 551 | $39.64 | $21.8K | Form 4 |
| 2026-04-10 | FULLER JULIE | Officer (Executive Vice President) | Grant / award / vesting (derivative) | 551 | $39.64 | $21.8K | Form 4 |
Ask the chat about ZTS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Zoetis (ZTS).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.